Paik S - Search Results

1

HER2 and choice of adjuvant chemotherapy for invasive breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-15.

Paik S, Bryant J, Tan-Chiu E, Yothers G, Park C, Wickerham DL, Wolmark N. Paik S, et al. J Natl Cancer Inst. 2000 Dec 20;92(24):1991-8. doi: 10.1093/jnci/92.24.1991. J Natl Cancer Inst. 2000. PMID: 11121461

2

Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer.

Paik S, Hazan R, Fisher ER, Sass RE, Fisher B, Redmond C, Schlessinger J, Lippman ME, King CR. Paik S, et al. J Clin Oncol. 1990 Jan;8(1):103-12. doi: 10.1200/JCO.1990.8.1.103. J Clin Oncol. 1990. PMID: 1967301

3

erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer.

Paik S, Bryant J, Park C, Fisher B, Tan-Chiu E, Hyams D, Fisher ER, Lippman ME, Wickerham DL, Wolmark N. Paik S, et al. J Natl Cancer Inst. 1998 Sep 16;90(18):1361-70. doi: 10.1093/jnci/90.18.1361. J Natl Cancer Inst. 1998. PMID: 9747867

4

Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma.

Fisher ER, Dignam J, Tan-Chiu E, Costantino J, Fisher B, Paik S, Wolmark N. Fisher ER, et al. Among authors: paik s. Cancer. 1999 Aug 1;86(3):429-38. doi: 10.1002/(sici)1097-0142(19990801)86:3<429::aid-cncr11>3.0.co;2-y. Cancer. 1999. PMID: 10430251 Clinical Trial.

5

HER-2 and choice of adjuvant chemotherapy in breast cancer.

Paik S, Park C. Paik S, et al. Semin Oncol. 2001 Aug;28(4):332-5. doi: 10.1016/s0093-7754(01)90127-7. Semin Oncol. 2001. PMID: 11498827 Review.

6

Statistical considerations in assessing molecular markers for cancer prognosis and treatment efficacy.

Dignam J, Bryant J, Paik S. Dignam J, et al. Among authors: paik s. Methods Mol Biol. 2002;184:169-89. doi: 10.1385/1-59259-242-2:169. Methods Mol Biol. 2002. PMID: 11889713 Review. No abstract available.

7

Real-world performance of HER2 testing--National Surgical Adjuvant Breast and Bowel Project experience.

Paik S, Bryant J, Tan-Chiu E, Romond E, Hiller W, Park K, Brown A, Yothers G, Anderson S, Smith R, Wickerham DL, Wolmark N. Paik S, et al. J Natl Cancer Inst. 2002 Jun 5;94(11):852-4. doi: 10.1093/jnci/94.11.852. J Natl Cancer Inst. 2002. PMID: 12048273

8

Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less.

Fisher B, Bryant J, Dignam JJ, Wickerham DL, Mamounas EP, Fisher ER, Margolese RG, Nesbitt L, Paik S, Pisansky TM, Wolmark N; National Surgical Adjuvant Breast and Bowel Project. Fisher B, et al. Among authors: paik s. J Clin Oncol. 2002 Oct 15;20(20):4141-9. doi: 10.1200/JCO.2002.11.101. J Clin Oncol. 2002. PMID: 12377957 Clinical Trial.

9

Effects of tamoxifen on benign breast disease in women at high risk for breast cancer.

Tan-Chiu E, Wang J, Costantino JP, Paik S, Butch C, Wickerham DL, Fisher B, Wolmark N. Tan-Chiu E, et al. Among authors: paik s. J Natl Cancer Inst. 2003 Feb 19;95(4):302-7. doi: 10.1093/jnci/95.4.302. J Natl Cancer Inst. 2003. PMID: 12591986

10

Lower-category benign breast disease and the risk of invasive breast cancer.

Wang J, Costantino JP, Tan-Chiu E, Wickerham DL, Paik S, Wolmark N. Wang J, et al. Among authors: paik s. J Natl Cancer Inst. 2004 Apr 21;96(8):616-20. doi: 10.1093/jnci/djhs105. J Natl Cancer Inst. 2004. PMID: 15100339

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,467 results

Search Page

Filters